Laidlaw & Co. Initiates Coverage On NewcelX with Buy Rating, Announces Price Target of $23

Benzinga · 1d ago
Laidlaw & Co. analyst Yale Jen initiates coverage on NewcelX (NASDAQ:NCEL) with a Buy rating and announces Price Target of $23.